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Large-scale analysis of expression signatures
reveals hidden links among diverse cellular
processes
Steven X Ge
Abstract
Background: Cells must respond to various perturbations using their limited available gene repertoires. In order to
study how cells coordinate various responses, we conducted a comprehensive comparison of 1,186 gene
expression signatures (gene lists) associated with various genetic and chemical perturbations.
Results: We identified 7,419 statistically significant overlaps between various published gene lists. Most (80%) of
the overlaps can be represented by a highly connected network, a “molecular signature map,” that highlights the
correlation of various expression signatures. By dissecting this network, we identified sub-networks that define
clusters of gene sets related to common biological processes (cell cycle, immune response, etc). Examination of
these sub-networks has confirmed relationships among various pathways and also generated new hypotheses. For
example, our result suggests that glutamine deficiency might suppress cellular growth by inhibiting the MYC
pathway. Interestingly, we also observed 1,369 significant overlaps between a set of genes upregulated by factor X
and a set of genes downregulated by factor Y, suggesting a repressive interaction between X and Y factors.
Conclusions: Our results suggest that molecular-level responses to diverse chemical and genetic perturbations are
heavily interconnected in a modular fashion. Also, shared molecular pathways can be identified by comparing
newly defined gene expression signatures with databases of previously published gene expression signatures.
Background
With a limited number of genes, cells have to effectively
coordinate their responses to diverse perturbations. Differ-
ent stimuli could activate the same molecular pathways
and thus induce overlapping sets of genes. A classic exam-
ple is response to cold, drought and salt stress in plants
[1]. Evoking an opposite response might be beneficial in
other circumstances. The MYC pathway, for example,
induces proliferative growth under favourable conditions,
but is suppressed by many stresses such as inflammation
[2]. Studying correlations between these diverse responses
compliments in-depth investigations focused on cellular
responses to individual stimuli and will enhance under-
standing of complex regulatory mechanisms.
There are many examples of the co-regulation of the
same set of genes in different biological processes. For
example, Chang et al. observed that the gene expression
signature of serum response in fibroblast predicts cancer
progression [3]. Similarly, diverse signaling pathways acti-
vated by growth factors induce broadly overlapping sets
of genes [4]. Ben-Porath et al. found that genes over-
expressed in histologically poorly differentiated tumors
are enriched with genes highly expressed in embryonic
stem cells [5]. On a larger scale, the Connectivity Map
[6] provides a database of expression profiles of cultured
cells treated with various compounds for the detection of
associations of small molecules with similar mechanism
of action. These studies are all based on the analyses of
gene expression data and provide important insight into
the relationship between different molecular pathways.
The objective of this study is to systematically compare
published gene sets and create a “molecular signature
map” that highlights correlations between diverse cellular
perturbations. Published gene lists, however, are not
readily available in a single source; they currently exist in
scattered journal articles in diverse formats. The pains-
taking task of extracting this information manually has
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first systematic effort to collect lists of differentially
expressed genes from microarray studies, which currently
includes about 958 mammalian gene sets [8]. Oncomine
is a web-based database system that focuses on cancer
related genomics data and includes both raw microarray
data and gene sets (referred to as “molecular concepts”)
[9]. The Molecular Signatures Database (MSigDB) was
constructed as a knowledgebase for the popular pathway
analysis program known as Gene Set Enrichment Analy-
sis (GSEA) [10]. Most of the L2L information is included
in MSigDB, which is by far the most comprehensive
source of published human gene sets.
Furthermore, several tools to analyze gene lists data
have been developed. Both the L2L and MSigDB web
sites provide user interfaces to detect significant overlap
of gene lists with their database. A similar approach,
known as molecular concept analysis, is available at the
Oncomine web site. In addition to using published gene
sets, users can also compare their lists against functional
gene sets, such as those derived from Gene Ontology
(GO), KEGG, etc. Such analyses will broaden under-
standing of gene sets and their relationships with var-
ious pathways and functional categories.
This work is an effort to study the whole picture of over-
lapping gene lists. This comprehensive analysis of MSigDB
gene sets related to chemical and genetic perturbations
will provide insights on the relationship of diverse cellular
processes. By representing overlaps between gene sets as
networks, we focus on the interpretation of the connec-
tions among diverse gene sets by taking advantage of the
methods for visualizing and analyzing complex biological
networks.
Results
Thousands of significant overlaps are identified
The Version 2.5 of MSigDB contains 1,186 gene sets in
the “C2: chemical and genetic perturbations” category
[10], manually compiled from over 300 publications. It
represents an important source of accumulated knowl-
edge of the molecular signatures of various genetic and
chemical perturbations. Except for about 99 gene sets
that are based on mouse studies, most of the sets are
derived from studies using human tissues or cells. The
total number of distinct genes across gene sets in all pub-
lications is 14,553. Each gene set has a name like “COL-
LER_MYC_DN,” where Coller is the first author of the
publication [11] followed by a brief description of the set,
such as “Genes down-regulated by MYC in 293T (trans-
formed fetal renal cell).”
The 1,186 gene sets have a median size of 42, but vary
greatly from 3 to 1,838 genes. Interestingly, the distribu-
tion is close to normal on a log scale (Additional File 1:
Figure S1). Some of the most frequently appearing genes
in these gene sets are cytokines and growth factors
(Table 1). As suggested by the number of PubMed
records associated with each of the genes, most of the
top genes have been studied extensively (Table 1). MYC,
STAT1, and ID2 are the three most common genes in
published gene sets in MSigDB. Interestingly, the tran-
scriptional repressor ID2 (inhibitor of DNA binding 2)
is frequently identified as differentially expressed, even
though it has been investigated in relatively few studies.
We carried out a comprehensive all-vs.-all comparison
of the 1,186 published gene sets using a Perl script
(available as Additional File 2). Based on the hypergeo-
metric distribution, we then calculated the likelihood of
observing the number of overlapping genes if these two
gene sets are randomly drawn without replacement
from a collection of 14,553 genes.
Using the Bonferroni correction for multiple testing,
we multiplied P values by the total number of compari-
sons. After correction, the number of significant overlaps
is 2,441. Some extremely significant (P < 1 × 10
-200) over-
laps are apparently justified by the biology. For example,
120 out of the 149 genes in the gene set “CHANG_SER-
UM_RESPONSE_UP” are shared with “SERUM_FIBRO-
BLAST_CORE_UP”,w h i c ho n l yh a s2 0 5g e n e s .
Therefore, even with the most conservative correction,
thousands of significant overlaps can be identified.
Since the Bonferroni correction could be too conser-
vative, we used the false discovery rate (FDR) procedure
[12] in further analysis. Although the tests are not statis-
tically independent due to the overlaps between sets, the
dependency should be considered a positive correlation,
and the FDR procedure is applicable [13]. The raw P-
values were translated into FDR to correct for multiple
testing [12]. Overlaps between gene sets from the same
study were considered trivial and were removed. With
FDR < 0.001 as a cut-off, we identified 7419 significant
overlaps between 958 gene sets.
Table 1 Top 20 most frequently appearing genes in
1,186 published gene sets in MSigDB
Gene
Symbol
Frequency
in
MSigDB C2
#PubMed
Records
Gene
Symbol
Frequency
in
MSigDB C2
#PubMed
Records
MYC 86 13323 TNFAIP3 54 201
STAT1 75 2719 CDC2 54 4052
ID2 66 364 IL8 52 675
CDKN1A 64 6713 HMGB2 52 151
IFITM1 62 41 RHOB 50 270
SERPINE1 59 6486 GADD45A 50 224
ISG15 58 192 PCNA 49 8179
VEGF 56 22283 CCND1 49 7243
CTGF 56 1024 ATF3 49 207
IL6 55 2100 TOP2A 48 136
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we used the same criteria to detect overlaps from data
generated under the null hypothesis. We generated
1,186 gene sets of the same sizes as those in MSigDB
but with genes drawn randomly from a pool of 14,553
distinct genes. With FDR < 0.001 as the cut-off, no sig-
nificant overlap was identified. The same results hold in
five repeated simulations. This simulation demonstrated
the significance of the 7,419 overlaps in MSigDB.
Modular organization of the gene set overlapping
network
Our results can be conveniently represented by an
undirected network, where nodes correspond to gene
sets and edges indicate significant overlaps (Figure 1).
An annotated version of this network with detailed
information on gene sets and overlaps can be found in
Additional File 3. This file can be read by the Cytoscape
software (http://www.cytoscape.org) [14] for easy access
and exploration. This same information is also provided
as an Excel file (Additional File 4). This network high-
lights correlations across expression signatures of
diverse biological processes, diseases, and cellular sti-
muli. This big network thus constitutes a “molecular
signature map,” in which individual perturbations are
placed in the context defined by all others.
This is a highly connected network with an average of
7.74 connections per gene set. Surprisingly, most (949)
of the 958 gene sets are connected to a dominant main
network. In this network, while most nodes are con-
nected to a small number of other gene sets, there are a
small number of gene sets that significantly overlap with
a large number of gene sets. This is similar to what has
been observed in many biological networks.
One noticeable feature of the molecular signature map
in Figure 1 is its modularity. We observed several clus-
ters of highly connected expression signatures. An effi-
cient way to organize a large number of responses to
diverse perturbations is to organize these responses into
modules. Figure 1 supports the notion that cells coordi-
nate their responses to various stimuli by the combina-
tion of multiple modules.
To identify these modules, or highly interconnected
sub-networks, we used the MCODE algorithm [15] to
analyze the network of 949 nodes. We identified 21 sub-
networks with four nodes or more. The biggest sub-net-
work was further partitioned into two due to its size
and topology. Thus, we obtained a total of 22 sub-net-
works. Table 2 lists these sub-networks with detailed
information on both biological themes and the most fre-
quent genes. These are the modules that cells use to
remain viable in diverse environments.
Many of these highly connected sub-networks reveal
clusters of gene sets derived from biologically similar
perturbations. This is evi d e n tf r o mt h ec o h e r e n tG O
terms enriched in genes shared by gene sets within sub-
networks (Table 2). We extracted 70 most frequently
appearing genes in each sub-network and conducted
enrichment analyses based on GO terms. See Additional
File 5 for the full list of these top genes in each module.
Some unexpected links reveal interesting similarities in
cellular responses to very different stimuli. We will dis-
cuss several of these sub-networks in the following sec-
tions. Additional sub-networks are discussed in
Additional File 1. For each sub-network, we examine
one or more examples of overlapping gene sets in
details. These examples are summarized in Table 3.
c-MYC oncoprotein and its relationships to serum
stimulation and interferon g
Some of the sub-networks confirm the overlapping of
genes in studies investigating similar perturbations. One
example is shown in Figure 2A (corresponding to Cluster
# 1 0i nT a b l e2 ) .F o u ro ft h es e v e ng e n es e t si nt h i ss u b -
network are clearly marked as target genes or are upregu-
lated by oncoprotein c-Myc. The gene set of Basso et al.
deals with hubs in gene regulatory networks; MYC is iden-
tified as a major hub [16]. Basso et al. also noticed that a
significant proportion of MYC target genes are regulatory
hubs [16]. Therefore, not surprisingly, the regulatory hubs
Figure 1 A highly connected network of published gene sets.
Nodes represent gene sets and edges represent significant overlaps.
We identified 7,419 significant overlaps (FDR < 0.001) among 958
published gene sets. Only 2,915 highly significant (FDR < 1.0 × 10
-6)
overlaps are shown in this figure. We observed a large number of
significant overlaps among diverse expression signatures organized
in a modular fashion.
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Page 3 of 13Table 2 Summary of 22 modules consisting of groups of heavily interconnected gene sets
ID #Sets Cluster
Density
Representitive GeneSet Biological
Theme
Most freqently shared
genes between gene sets
Most
significantly
enriched GO
Term
P values
1a 31 13.5 P21_P53_ANY_DN_49 (Sup. Figure 1) Cell cycle,
especially M
phase
FOXM1,CCNB1,KIF2C,KIF11,
CDC2,CCNB2,UBE2C,CDC20,
MKI67,DLG7
Cell Cycle 2.80E-45
1b 29 12.8 DER_IFNB_UP_93 (Figure 3) Immune
response/
interferon
MX2,MX1,OAS1,STAT1,OAS2,
ISG15,IFITM1,IFIT3,IRF7,
IFI27Response to virus
1.30E-19
2 15 3.7 IL1_CORNEA_UP_63 Inflammatory
response/IL1
IL1B,CCL4,PLAUR,CXCL2,CCL5,
TNFAIP3,CD44,IER3,NFKBIA,
PLEK
Immune
system process
1.00E-15
3 16 3.6 TNFA_NFKB_DEP_UP_18 (Figure 5) Inflammatory
response/
TNFa related
GPNMB,CXCL1,SOD2,MMP9,
CXCL5,CCL2,CHI3L1,CXCL3,
CD9,IL1B
Immune
system process
2.70E-20
4 14 3.1 GENOTOXINS_ALL_4HRS_REG_27 (Figure 4) Cell cycle,
DNA damage
response
CKS2,ECT2,MAD2L1,BUB1,
AURKA,CCNB2,CKS1B,PRC1,
TRIP13,RRM2
Cell Cycle 3.10E-22
5 20 2.1 HOHENKIRK_MONOCYTE_DEND_DN_122 Inflammatory
response/
blood cells
STAT1,RAB2,CXCL3,HSPH1,
SFRS3,S100A4,S100A8,TOP2A,
ACTR1B,ANXA1
inflammatory
response
7.40E-04
6 14 2.0 TGFBETA_ALL_UP_80 Cell adhesion,
differentiation
IGFBP3,COL6A3,THBS2,CSPG2,
SERPINE1,COL1A2,COL3A1,
COL6A1,LOX,TIMP1
Cell adhesion 9.60E-07
7 6 2.0 ESR_FIBROBLAST_DN_18 cell
differentiation
GNPNAT1,LCK,NDRG1,SOX7,
TAF1C,TP53I11,ZNF507,CEPT1,
GABBR1,HGF
–
8 35 2.0 HYPOXIA_REG_UP_38 (Figure 6) Cell cycle
arrest
POSTN,MTHFD1,MYC,TFRC,
COL6A3,CSPG2,CTPS,SNRPA1,
WEE1,ADORA2B
cell cycle arrest 8.30E-02
9 18 1.7 UVC_XPCS_4HR_DN_242 Down-
regulated by
UV, TNFa
ITGB5,AXL,ARL4C,RGS4,ACTA2,
ARHGAP1,ARL6IP5,CAP2,
COL1A2,CYFIP2
Signal
Transduction
7.50E-04
10 7 1.7 SCHUMACHER_MYC_UP_54 ( Figure 2) MYC target
genes
NME1,HSPE1,HSPD1,LDHA,
TFRC,APEX1,CDK4,EBNA1BP2,
ENO1,FKBP4
Intracellular
organelle
lumen
1.80E-02
11 5 1.6 GNATENKO_PLATELET_UP_47 Platelet genes PF4,PPBP,TMSB4X,GPX1,
HIST2H2AA4,ACTB,B2M,CCL5,
CD99,CFL1
*
12 7 1.6 ADIPOCYTE_PPARG_UP_16 Lipid
metabolic
process
ADIPOQ,AQP7,DGAT1,FASN,
RETN,CIDEC,COX7B,NDUFS1,
NR1H3,SCARB1
Lipid metabolic
process
7.10E-04
13 27 1.6 CHANG_SERUM_RESPONSE_DN_194 SC4MOL,ACTB,HMGCS1,BAK1,
ZYX,SCD,BAD,CTNNA1,FDPS,
ITGB4
hemopoiesis 3.60E-03
14 4 1.5 CISPLATIN_PROBCELL_UP_17 ABI1,CDKN1A,EI24,LPIN1,TOB1,
TP53INP1,TXNIP,ABLIM1,
CARHSP1,H2AFJ
*
15 6 1.3 UVC_LOW_ALL_UP_19 Response to
DNA damage,
UV
BTG2,CDKN1A,GDF15,BTG1,
DDB2,PLXNB2,FDXR,GPRC5A
*
16 7 1.3 FLECHNER_KIDNEY_TRANSPLANT_WELL_UP_565 RAB1A,ATP2A2,COL1A2,PGK1,
RAB2,SPARC,WEE1,AGL,CFLAR,
DNAJA1
*
17 5 1.2 CMV_HCMV_TIMECOURSE_ALL_UP_470 IL6 induced MX1,IRF4,TNFSF10,CCNC,
DNAJB9,GATM,GNA13,HBEGF,
ICAM1,JUNB
Response to
stimulus
4.80E-02
18 5 1.2 REN_E2F1_TARGETS_50 E2F1 target
genes
PCNA,TOP2A,KIAA0101,POLA2,
RFC4
*
19 6 1.2 STEMCELL_HEMATOPOIETIC_UP_1452 Stem cell
enriched
ATP5D,BTBD14A,EEF1A1,GLUL,
NTAN1,NUDCD2,PCGF2,
ATP1A1,CD151,DYNC1H
*
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Page 4 of 13are enriched with MYC targets. Significant overlaps
between these five studies of MYC related genes are iden-
tified by our analysis, which reassures us that our analysis
can identify biologically related gene sets.
This sub-network also highlights a gene set of serum
response genes that overlaps with MYC gene sets [17]. The
c-Myc oncogene is known to mediate responses to serum
stimulation [18,19] and trigger proliferative growth in a
favourable environment. The overlaps between two MYC
target gene sets and genes downregulated by interferon g
(IFNG) were unexpected. However, as IFNG inhibits cell
growth through suppression of c-MYC expression [2],
upregulation of IFNG causes downregulation of MYC tar-
get genes. We could generalize that overlaps between a set
of “X upregulated genes” with “Y downregulated genes”
possibly indicate repressive interactions between factors X
and Y. Such overlaps are highlighted in dashed red lines in
the networks.
We conclude that most of the gene sets in this sub-net-
work are directly or indirectly related to MYC protein. Fig-
ure 2B shows the list of 15 genes that appear three times
or more in these seven gene sets. We think this could be a
reliable list of MYC target genes based on multiple
publications.
A sub-network for pathogen response
Another example of a similar perturbation is shown in
Figure 3, which corresponds to sub-network #2 in
Table 2. As this sub-network is so densely connected,
only overlaps with extremely high significance (FDR <
1×1 0
-20) are shown. Most of the 29 gene sets in this
sub-network are regulated by interferons a and b that
mediate response to pathogens. Overlaps among these
sets are remarkably significant. For example, 35 out of
the 66 DER_IFNA_UP genes are also included in the
65 genes in IFN_BETA_UP.
Correlations between several other gene sets and
interferon a and b pathways are not obvious. The
“TAKEDA_NUP9_HOXA9_3D_UP” gene set includes
genes upregulated by the fusion protein NUP98-
HOXA9, which occurs in acute myeloid leukemia [20].
Takeda et al. noted that transduction of this fusion pro-
tein induces “upregulation of IFNb1 and is accompanied
by marked upregulation of IFN-induced genes” [20].
Thus, their gene list must contain INFB target genes.
The “BENNETT_SLE_UP” gene set includes genes sig-
nificantly up-regulated by systemic lupus erythematosus
(SLE) patients [21]. The major conclusion and surprising
finding of this study are that the SLE active expression
Table 2 Summary of 22 modules consisting of groups of heavily interconnected gene sets (Continued)
20 4 1.0 ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_DN_4 Leukemia
related
ELA2,BLNK,BZRAP1,CD24,CD7,
CEBPD,CST7,DNTT,HGF,KCNE1L
*
21 4 1.0 NADLER_OBESITY_DN_38 Obesity
down,
adipocyte up
PPA1,ACSL1,AGT,ALDH2,CFD,
CRAT,FABP4,LDHB,PC,PPARG
*
Cluster density is defined by dividing the number of significant overlaps (edges) by the number of gene sets within the sub-network.
* Less than 20 genes.
Table 3 A summary of overlaps that were discussed in details in this paper
Overlapping Gene Sets Explanation and supporting references Repressive?
Chang_Serum_Response_up &
Schumacher_MYC_up
The c-Myc oncogene mediates response to serum stimulation and triggers proliferative
growth [18,19].
Sana_IFNG_Endothelial_Dn &
Zeller_MYC_Up, MYC_Targets
Interferon g (IFNG) inhibits cell growth through suppression of c-MYC expression [2]. Yes
Taketa_NUP9_HOXA9_3d_Up and
interferon a and b gene sets
Transduction of fusion protein NUP98-HOXA9 induces “up-regulation of IFNb1 and is
accompanied by marked up-regulation of IFN-induced genes” [20].
CMV (cytomegalovirus) infection & Various
cytokine regulated gene sets
Host cell response to CMV infection might be mediated by these cytokines.
StemCell_Embryonic_up &
BRCA_Prognosis_Neg
Aggressive tumors share some expression signature of embryonic stem cells [5].
P53_Genes_All & Zeller_MYC_Dn p53 represses the oncogene MYC possibly through miRNA-145 [45]. Yes
Gay_YY1_up & P53_Genes_All YY1 inhibits the activation of p53 [36]. Yes
Cancer_undifferentiated_Meta_up &
IDX_TSA_UP_Cluster3
Genes involved in TSA-induced differentiation of fibroblasts into adipocytes are also
upregulated in undifferentiated tumors.
Peng_Glutamine_Dn & several MYC
upregulated gene sets
Glutamine starvation might suppress cell growth by repression of MYC pathway. Yes
Manalo_hypoxia_Dn,
StemCell_Embryonic_up, Le_Myelin_up
Cell cycle genes are regulated by hypoxia, stem cells, and growth after wounding. Partly
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Page 5 of 13profile is “distinguished by a remarkably homogeneous
gene expression pattern with overexpression of granulo-
poiesis-related and interferon (IFN)-induced genes” [21].
Finally, seven gene lists in this sub-network are related
to CMV (cytomegalovirus) infection [22]. The finding
that these gene sets are highly significantly related to
IFN-induced genes indicates that host cell response to
CMV infection might be mediated by these cytokines.
Figure 2 Sub-network #10: MYC target genes. A) The sub-network of MYC target genes. Nodes represent gene sets and edges represent
significant overlaps. The size of the node indicates the number of genes in the gene set, which is also numerically labelled by the number at
the end of each gene set name. The thickness of the edges is proportional to significance (-log10(FDR)). The labels of edges indicate the
number of overlapping genes. Red dashed edges represent repressive connections between “X” upregulated genes and “Y” downregulated
genes. The same settings were used to generate subsequent figures in this paper. Gene sets explicitly related to MYC oncoprotein are
highlighted in yellow. B) List of 15 genes (columns) that appear three times or more in these seven gene sets (rows). Red indicates that a gene
is included in a gene set. This figure shows that our approach can identify overlaps between biologically related gene signatures.
Figure 3 Sub-network #1b: Expression signature of interferons a and b. Only edges with extremely significant overlaps (FDR <1.0 × 10
-20)
are shown here. Nodes represent gene sets and edges represent significant overlaps. The size of the node indicates the number of genes in the
gene set, which is also numerically labelled by the number at the end of each gene set name. The thickness of the edges is proportional to
significance (-log10(FDR)). The labels of edges indicate the number of overlapping genes. This figure shows that expression signatures of
interferon a and b are very similar across multiple studies and that pathogen responses rely on a core set of shared genes.
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quently shared by gene sets in this sub-network have
coherent biological functions. The most significantly
enriched functional category is “Response to virus”
(P <1.3 × 10
-19 after Benjamini correction of multiple
testing), followed by “Immune response” (P <1.5 × 10
-12).
Out of the 70 genes, 18 and 24 are associated with
“Response to virus” and “Immune responses”, respec-
tively (Table 2). These results indicate that the gene lists
in this sub-network are dominated by immune responses
triggered by various conditions.
Stem cell related genes as predictors of poor prognosis
for breast cancer
S u b - n e t w o r k# 4i nT a b l e2i n c l u d e sd i v e r s eg e n es e t s
(Figure 4). The “StemCell_neural_up” set includes 1,838
genes highly expressed in mouse neural stem cells,
compared to differentiated brain and bone marrow cells
[23]. Another related set from the same study is “Stem-
Cell_Embryonic_up” representing genes enriched in
embryonic stem cells. Interestingly, these gene sets
intersect significantly with genes associated with poor
prognosis in breast cancers. The “BRCA_Prognosis_Neg”
and “Vant Veer_Breast_Outcome_Good_vs_Poor_Dn”
are derived from the same publication [24] and are
extracted from the same list of genes whose higher
expression predicts poor outcome. The latter includes
many genes represented by clone IDs not properly
mapped to gene symbols.
The overlap between stem cell and breast cancer
prognosis genes is highly significant: 42 (44%) of the 95
genes in “BRCA_Prognosis_Neg” are highly expressed in
embryonic stem cells ("StemCell_Embryonic_up”,w i t h
FDR <1 × 10
-11). These 42 genes are enriched with 11
Figure 4 Sub-network #4: Stem cell related gene sets and breast cancer prognosis predictors are linked. Nodes represent gene sets and
edges represent significant overlaps. The size of the node indicates the number of genes in the gene set, which is also numerically labelled by
the number at the end of each gene set name. The thickness of the edges is proportional to significance (-log10(FDR)). The labels of edges
indicate the number of overlapping genes. The labels of edges indicate the number of overlapping genes. Red dashed edges represent
repressive connections between “X” upregulated genes and “Y” downregulated genes. We observed overlaps between stem cell related
expression signature and breast cancer prognosis predictors. Expression of some cell cycle related genes is shared between stem cells and
invasive breast cancers.
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0.00001), 20 of which are related to organelle parts of
cell structure (Benjamini corrected P < 0.008). The sig-
nificant overlap between breast cancer prognosis genes
and stem cell genes thus highlights the similarity in
expression profiles between aggressive tumors and stem
cells. This is supported by a more in-depth meta-analy-
sis of gene expression data [5].
Another interesting overlap is between stem cell gene
lists with genes down-regulated by hypoxia. Thirty eight
(42%) of the 91 genes in “Manalo_hypoxia_Dn” set are
included in “Stem_Cell_Embryonic_up” with FDR <1 ×
10
-12. Of these 38 genes, 12 are related to GO Term
“DNA replication” with Benjamini P value <8.5 × 10
-9.
Cell cycle genes are also enriched. One of the overlapped
genes is BRCA1. Other lists in this cluster include “Geno-
toxins_All_4hrs_Reg,” which is a list of genes that are
commonly regulated by six types of genotoxins [25]. The
overlapped genes are also mostly cell cycle related,
including BUB1, CDC20, CCNB1, etc. The “Le_MYE-
LIN_Up” set contains genes upregulated after sciatic
nerve injury. Thus, these genes might be related to
growth after wounding.
We also compared gene lists in this sub-network with
sets of genes (NRC-1 to NRC-9) recently identified as
breast cancer prognostic markers by Li et al. [26]. We
identified modestly significant (unadjusted P value < 1 ×
10
-4) overlaps between three gene sets in this subnetwork
with two gene sets related to cell cycle (NRC-1 and NRC-
5) and one related to cell growth (NRC-9). See Additional
File 1: Figure S3 for more information. These overlaps
again suggest that cell cycle genes are important in pre-
dicting breast cancer survival. But further study is clearly
needed to systematically compare the NRC and other
breast cancer related gene sets, many of which are not
included in the version 2.5 of MSigDB database.
Glutamine starvation strongly downregulates MYC target
genes
S u b - n e t w o r k# 8i nT a b l e2i ss h o w ni nF i g u r e5 ,a n d
includes diverse gene sets ranging from ultraviolet (UV)
treatment, glutamine starvation, BRCA1 overexpression,
etc. The connection between “Appel_Imatinib_up” and
“Li_Fetal_vs_WT_kidney_up” confirms the regulation of
differentiation by Imatinib, a new tyrosine kinase inhibi-
tor. Imatinib can inhibit dendritic cell differentiation
[27]. The “Li_Fetal_vs_WT_kidney_DN” gene set repre-
sents genes highly expressed in Wilms’ tumor (WT)
compared with fetal kidneys [28]. WT is characterized
by arrested cellular differentiation. Even though the
cells/tissues are different in these two studies, we were
able to detect this moderately significant overlap.
We focus our attention on the “Peng_Glutamine_Dn”
gene list that is associated with glutamine starvation in
human BJAB B-lymphoma cells [29]. An unexpected
connection is that genes downregulated by glutamine
starvation contain many MYC target genes. In the
whole network this is most evident as the “Peng_Gluta-
mine_Dn” list significantly overlaps with almost all
MYC related gene sets. The neighborhood of this gene
set is in the molecular signature map in Additional File
1: Figure S2. Yuneva et al. showed that glutamine but
not glucose starvation induces MYC-dependent apopto-
sis in human cancer cells [30], but the mechanism is
unknown. On the other hand, Wise et al. found that
overexpression of MYC promotes glutaminolysis and
leads to cellular addiction to glutamine in cancer cells
[31]. These study results may lead to the development
of targeted killing of cancer cells that rely on high levels
of glutamine uptake. We found no report on whether
glutamine starvation inhibits the MYC pathway. If this
is indeed true, as suggested by the overlapping of these
gene sets, then the closely related nature of glutamine
metabolism and the MYC pathway will need to be eval-
uated more closely.
To further confirm the link between glutamine depri-
vation and the MYC pathway, we downloaded and re-
analyzed the raw DNA microarray data on glutamine
starvation [29]. Using the GSEA program, we analyzed
the whole dataset for enriched gene sets. The enriched
gene sets are shown as Additional File 1: Table S1. One
pathway that showed up is the proteosome degradation
pathway, in which nutrient deficient cells suppress pro-
tein degradation as a means for survival. The most
noticeable pathways are multiple MYC target gene sets
downregulated at highly significant levels, confirming
our observation based on gene set overlaps.
Figure 6 is a heatmap of relative expression levels of a
list of 42 MYC target genes compiled from multiple stu-
dies of MYC transcriptional targets [32]. Glutamine and
leucine deficiencies, but not glucose deficiency, strongly
downregulate many MYC target genes. The anticancer
drug rapamycin has a similar effect on these genes, sug-
gesting that rapamycin mimics amino acid starvation.
Downregulation is strongest after 24 hours of nutrient
deficiency, or 12 hours after rapamycin treatment. Inter-
estingly, glutamine and leucine starvation only lead to a
modest decrease in MYC gene expression; rapamycin
treatment even seems to upregulate its expression. This
raises questions regarding the mechanism by which
these target genes are downregulated. Some hints come
from the well-studied effect of rapamycin. Rapamycin
inhibits the TOR pathway, which regulates cell growth
and cell cycle progression in many species. Rapamycin
has been shown to downregulate MYC post-transcrip-
tionally, by inhibiting mRNA translation [33]. Therefore,
it is possible that glutamine starvation would have a
similar course of action.
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transcription factors including ATFs and C/EBP factors,
and such response might be cell line- or species-depen-
dent (See [34] for review). Indeed, our further analysis
of another set of DNA microarray data [35] suggests
that glutamine starvation does not cause downregulation
of Myc target genes in mouse hepatoma cells (data not
shown). However, for this specific B-lymphoma cell line
studied by Peng et al. [29], the suppression of the MYC
pathway is strongly supported by gene set overlaps and
raw DNA microarray data analysis.
Repressive interactions between pathways
Interestingly, we identified thousands of overlaps corre-
sponding to repressive interactions between different
pathways. These are marked by overlaps between a set
of genes downregulated by factor “X” (i.e., interferon
gamma) and another set of genes upregulated by factor
Figure 5 Sub-network #8: Glutamine starvation and c-Myc genes. The glutamine starvation down-regulated gene set is highlighted in
yellow, which is connected to sets of MYC target genes. Nodes represent gene sets and edges represent significant overlaps. The size of the
node indicates the number of genes in the gene set, which is also numerically labelled by the number at the end of each gene set name. The
thickness of the edges is proportional to significance (-log10(FDR)). The labels of edges indicate the number of overlapping genes. The labels of
edges indicate the number of overlapping genes. Red dashed edges represent repressive connections between “X” upregulated genes and “Y”
downregulated genes. The “Peng_Glutamine_Dn” list significantly overlaps with almost all MYC related gene sets.
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Page 9 of 13“Y” (MYC oncogene). Among the total of 7,419 signifi-
cant overlaps identified, 1,369 (18.4%) belong to this
category (up-down). For comparison, 2,762 (37.2%)
overlaps are explicitly in the same direction (i.e., up-up
or down-down).
Besides the IFNG and MYC, several examples are dis-
cussed in previous sections (See Table 3 for a full list).
These include the overlap between P53_Genes_All and
Zeller_MYC_Dn, which is supported by the fact that
p53 represses the MYC oncogene [36]. Additional file 4
includes many repressive overlaps not discussed. One of
the very significant repressive overlaps, for example, is
between Alzheimers_Disease_Dn and StemCell_Neur-
al_Up. There are 276 genes that were found to be
downregulated in Alzheimer’s disease but were upregu-
lated in neural stem cells. Detailed GO analysis shows
that these genes are enriched with ubiquitin-dependent
protein catabolic process (P < 10
-7). This is consistent
with the notion that Alzheimer’s disease is one of disor-
ders related to ubiquitin protein catabolic process [37].
T h ep r e v a l e n c eo fr e p r e s s i v ei n t e r a c t i o n sa m o n gv a r -
ious molecular pathways highlights the complexity of
cellular control machinery. This result also suggests the
necessity of paying close attention to the downregulated
genes and cross-checking them with upregulated genes
in other situations.
Discussion
T h eh i g h l yc o n n e c t e dn a t u r eo ft h e1 , 1 8 6g e n es e t si s
surprising. An average gene set overlaps with more than
seven gene sets, above a significant level of FDR < 0.001.
Moreover, the majority (80%) of the 1,186 gene sets are
Control
Low
glutamine Control
Low
leucine
Time
Control RapamycinTreated Control
Low
glucose
Figure 6 Expression of c-Myc target genes in B-lymphoma cells upon glutamine, leucine and glucose starvation as well as rapamycin
treatment. Red and green denote higher and lower expression, respectively. Glutamine and leucine deficiencies, but not glucose deficiency,
strongly downregulate many MYC target genes. The anticancer drug rapamycin has a similar effect on these genes, suggesting that rapamycin
mimics amino acid starvation.
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Page 10 of 13connected directly or indirectly as one big network. In
other words, any newly defined gene sets will have
approximately an 80% chance of having at least one sig-
nificant overlap with a gene set in MSigDB database.
Our results suggest that many seemingly unrelated sti-
muli/perturbations may activate or deactivate the same
molecular pathways. We have discussed several unex-
pected overlaps in our paper while analyzing sub-net-
works in previous sections. One example is the shared
genes among MYC target genes, serum stimulation, and
interferon gamma over-expression. Our data-driven ana-
lysis confirms the connection between them: serum sti-
mulation and interferon gamma up- and down-regulates
MYC target genes, respectively.
The observation that most of the gene sets are con-
nected to one dominant network can be explained in
several ways. Researchers might be biased and focus on
a small set of essential processes in cells, which would
give rise to a connected network. Similarly, the MSigDB
could have been selectively compiled. Another explana-
tion for the observation is that cells respond to diverse
perturbations with overlapping genes, resulting in the
observed heavily connected networks. This explains the
MYC pathway involvement in response to diverse sti-
muli. We believe that all of these factors contribute to
the connectivity of the network.
An implication from this finding is to compare new
gene lists obtained from genomics studies to big data-
bases of previously published gene sets. Interpretation of
gene lists remains a challenge in high-throughput geno-
mics studies. Algorithms and databases are available and
can be used to detect overrepresented genes belonging
to the same pathway, GO category, target genes of tran-
scription factors, etc. Alternatively, new gene lists can
be compared with all published gene lists. Our analysis
showed that very different biological processes can share
a gene expression signature. Comparison with thousands
of published gene sets will help in the interpretation of
new gene lists, with the contextual molecular perturba-
tion map. This is indeed similar to queries of nucleic
acid sequence databases for the annotation of new
sequence entries. MSigDB already has a user-friendly
interface that enables users to upload their gene lists
and compare them with all archived gene sets.
One of the drawbacks of this study is that we used
gene sets from both human and mouse studies, and
comparisons within the same species often involved dif-
ferent types of tissues or even cell lines. We included as
many gene sets as possible based on the rationale that
a) overlaps between divergent molecular pathways in
these species/tissues would not be detected and b) sig-
nificant overlaps, once detected, would suggest con-
served molecular mechanisms across species/tissues.
There are some evidence based on studies of yeast [38]
and bacteria [39] suggesting that gene regulatory net-
works are remarkably flexible, and large scale rewiring is
possible. Another limitation of this study is that our
results, the highly connected modules of gene lists, were
mainly validated through speculative discussions based
on literature. We discussed only a subset of the modules
that we deemed interesting. Two additional sub-net-
works related to p53 signalling and cell differentiation
are discussed in Additional File 1. Further study is
clearly needed to verify the identified links between
diverse biological perturbations.
Conclusions
Despite the fact that DNA microarray studies might be
inconsistent across laboratories [40], we identified thou-
sands of statistically significant overlaps between pub-
lished gene lists. Summarized as a molecular signature
map, our results provide key insights into underlying
connections of diverse perturbations. We have found
evidence that the molecular signature map is 1) highly
interconnected, suggesting that overlapping sets of genes
are used over and over again by cells to respond to var-
ious stimuli, and 2) modularly organized, suggesting that
different responses are coordinated via functional
modules.
Methods
Data source
We downloaded “C2” gene set files (v2.5 updated April
7, 2008) of the MSigDB [10] that contain 1,186 gene
sets that represent chemical and genetic perturbations
manually extracted from publications. This database also
includes gene sets contributed by individual researchers
and other similar databases such as the List of List
Annotated (L2L) database [8].
Statistical and network analyses
We developed a set of Perl scripts to analyze the origi-
nal gene set database and evaluate the overlapping
genes between all pairs. The P value for determining the
significance of overlaps between two gene sets is calcu-
lated based on the hypergeometric distribution using the
statistical computing software R (http://www.r-project.
org). The original P values are then converted into false
d i s c o v e r yr a t e( F D R )[ 1 2 ] .O v e r l a p sw i t hF D R<0 . 0 0 1
were considered significant. Our approach is similar to
the method used by Newman and Weiner, except that
they used binominal distribution to approximate the
hypergeometric distribution for faster calculation [41].
We used undirected graphs to represent the overlap-
ping information across thousands of gene sets. A signifi-
cant overlap defines an edge between the two nodes that
represent the gene sets. In the network file, each edge has
properties representing the number of common genes,
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Page 11 of 13names of the common genes and FDR value. Each node
has a name, a one-sentence description and the entire
gene set. The network file, available as Additional File 3,
thus includes a comprehensive account for all “C2” gene
sets in MSigDB. The network is visualized using Cytos-
cape software version 2.6.3 [42], and highly intercon-
nected sub-networks were identified using MCODE
version1.3 [15] with default settings.
To identify statistically enriched GO terms we selected
the top 70 most frequently appearing genes in each sub-
network and analyzed these gene lists with the DAVID
web site (http://david.abcc.ncifcrf.gov/) [43,44]. If the
number of genes shared by gene sets was smaller than
70, only the genes that appeared at least twice were
used. The most significant terms for all GO biological
process terms are listed in Table 2.
DNA microarray data analysis
T h eD N Am i c r o a r r a yd a t a s e t(Affymetrix .CEL files) of
glutamine starvation [29] was downloaded from the
homepage of the research group (http://jura.wi.mit.edu/
sabatini_public/rapachip2/frameset1.html). The data
were re-analyzed using an RMA algorithm. Genes were
ranked by average fold change over 12 hours and 24
hours of glutamine starvation compared to normal con-
trol. The ranked gene sets were used for pathway analy-
sis with the GSEA algorithm [10].
Additional material
Additional File 1: Supplementary figures and table.
Additional File 2: Perl script used to identify overlaps between
gene sets. This program will accept a file in *.GMT format, in which
each line defines a gene set.
Additional File 3: A molecular signature map. This is a file to be
opened by Cytoscape. It contains a large network representing the
significant overlaps between diverse molecular signatures.
Additional File 4: List of overlapping gene lists. This is an Excel file
that contains lists of significant overlaps between gene sets. Repressive
overlaps are identified as “rep” in the third column.
Additional File 5: Genes shared by multiple gene sets in sub-
networks.
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